AI pioneer Innoplexus and phytopharmaceutical company DrD are partnering toRead More
Partnering to unlock the true potential of cannabis in medical care
Archives: News
Innoplexus @ Machine Intelligence Summit, Berlin 2017
Innoplexus AG proudly announces that our founder and CEO, Dr Gunjan Bhardwaj will be on the panel discussion at Machine Intelligence Summit to be held on 14th July 2017, in Berlin, Germany. The panel discussion is around “From Past Learning to Predictive Future” at 13:45 CET on Friday at Deutsche Telekom Hauptstadtrepräsentanz Französische Straße 33a-c, …
Innoplexus @ Machine Intelligence Summit, Berlin 2017 Read More »
Accelerating innovation in Pharma with Artificial Intelligence & Big Data
As Kevin Rands, (a contributor at CIO.com) has stated in his blog “Data is the lifeline of any business”, and truly said, it remains the heart of businesses for life sciences and pharmaceutical industries. A lot still relies upon data while conducting research which is mostly done through traditional methods. As many top notch business …
Accelerating innovation in Pharma with Artificial Intelligence & Big Data Read More »
Innoplexus Proudly Announces the Launch of its Product iPlexus, at Bio-IT World, 2017
Innoplexus unveiled iPlexus at Bio-IT, 2017, Boston. iPlexus.ai is an end-to-end platform for Life Sciences which leverages Artificial Intelligence (AI) to cut the drug development time, from synthesis to approval, significantly. It generates continuous intelligence and insights, across discovery, clinical development, regulatory and commercial stages of drug development, spanning all major therapeutic areas and indications. …
Innoplexus Proudly Announces the Launch of its Product iPlexus, at Bio-IT World, 2017 Read More »
Innoplexus featured on Inc.
3 Ways Big Data and Analytics are Making Big Changes in Healthcare The technologies behind the next wave in healthcare innovation. Information is the new currency of innovation. With data flowing from countless new sources every day, the opportunities to dig in and learn more about the world around us have never been greater. Sometimes …
Innoplexus talks about Cybersecurity with Entrepreneur.com
Innoplexus talks about Cybersecurity with Entrepreneur.com Are Indian Tech Start-ups Robust Enough To Run Fast With Nation’s Digital Drive? The Zomato security breach puts a question mark on the information handling ability of start-ups The digital drive in India has altered the functioning of the industrial sector and put it on a fast track. In …
Innoplexus talks about Cybersecurity with Entrepreneur.com Read More »
Innoplexus at Bio-IT World
Excited to announce that Innoplexus is a gold sponsor of Bio-IT World Conference & Expo which is a 3 day event being held from 23rd May to 25th May 2017 at the Seaport World Trade Center in Boston, United States Of America. This event will feature various sectors from the Bioinformatics industry. Our Founder and …
Innoplexus Featured in DataQuest
Innoplexus launches iPlexus to transform decision support in the Life Sciences Industry Innoplexus, the technology and product development company focused on AI and advanced analytics, announced the launch of its product iPlexus, an end to end platform for Life Sciences which leverages artificial intelligence to generate continuous intelligence and insights across discovery, clinical development, regulatory …
Innoplexus signs MoU to provide academic license for its iPlexus platform to Regional Cancer Centre, Gwalior, India
Innoplexus is proud to announce our collaboration with the Regional Cancer Centre, Gwalior. Innoplexus has executed an MoU to provide an academic license for its iPlexus platform to RCC, Gwalior, India. The academic license allows doctors and researchers with free access to iPlexus. Doctors and researchers will be able to gain insights into the latest …
German VC firm invests in Data as a Service startup Innoplexus
Innoplexus, a Germany- and India-based Data as a Service (DaaS) startup, has closed an undisclosed sum in pre-Series A funding from HCS, a Germany-based Venture VC firm. With the capital, the startup plans to file more patent applications, further develop its trademark platform iPlexus, and invest in marketing.